Literature DB >> 20852084

Stiff heart syndrome.

Satya S Bhupathi1, Sreelatha Chalasani, Roxann Rokey.   

Abstract

Isolated cardiac amyloidosis, or "Stiff Heart Syndrome," is a rare manifestation of amyloidosis. Some degree of cardiac amyloid deposition is common in elderly patients, as reported in prior post-mortem studies; however, isolated cardiac involvement with predominantly cardiac symptoms and no evidence of systemic disease is a rare presentation. Establishing the correct diagnosis, even with the use of extensive testing including amyloid typing, understanding the clinical significance, and management can be challenging in such cases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20852084      PMCID: PMC3134435          DOI: 10.3121/cmr.2010.899

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  56 in total

1.  Diagnosing primary amyloidosis.

Authors:  Morie A Gertz
Journal:  Mayo Clin Proc       Date:  2002-12       Impact factor: 7.616

2.  Clinical outcome and survival of secondary (AA) amyloidosis.

Authors:  F Tanaka; K Migita; S Honda; T Fukuda; M Mine; T Nakamura; S Yamasaki; H Ida; A Kawakami; T Origuchi; K Eguchi
Journal:  Clin Exp Rheumatol       Date:  2003 May-Jun       Impact factor: 4.473

3.  Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts.

Authors:  R Liao; M Jain; P Teller; L H Connors; S Ngoy; M Skinner; R H Falk; C S Apstein
Journal:  Circulation       Date:  2001-10-02       Impact factor: 29.690

Review 4.  Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management.

Authors:  Walid Hassan; Hani Al-Sergani; Walid Mourad; Rashed Tabbaa
Journal:  Tex Heart Inst J       Date:  2005

Review 5.  How I treat amyloidosis.

Authors:  Raymond L Comenzo
Journal:  Blood       Date:  2009-07-17       Impact factor: 22.113

6.  Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation.

Authors:  S Dubrey; A Pollak; M Skinner; R H Falk
Journal:  Br Heart J       Date:  1995-11

7.  Survival of patients with primary (AL) amyloidosis. Colchicine-treated cases from 1976 to 1983 compared with cases seen in previous years (1961 to 1973).

Authors:  A S Cohen; A Rubinow; J J Anderson; M Skinner; J H Mason; C Libbey; H Kayne
Journal:  Am J Med       Date:  1987-06       Impact factor: 4.965

8.  Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients.

Authors:  E Arbustini; G Merlini; A Gavazzi; M Grasso; M Diegoli; R Fasani; V Bellotti; G Marinone; P Morbini; B Dal Bello
Journal:  Am Heart J       Date:  1995-09       Impact factor: 4.749

9.  Isolated cardiac amyloidosis associated with sudden death.

Authors:  P F Lindholm; M R Wick
Journal:  Arch Pathol Lab Med       Date:  1986-03       Impact factor: 5.534

Review 10.  The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies.

Authors:  G Merlini; P Westermark
Journal:  J Intern Med       Date:  2004-02       Impact factor: 8.989

View more
  3 in total

Review 1.  Proteomics in molecular diagnosis: typing of amyloidosis.

Authors:  Dorothy Loo; Peter N Mollee; Patricia Renaut; Michelle M Hill
Journal:  J Biomed Biotechnol       Date:  2011-10-29

2.  Cardiac MR elastography for quantitative assessment of elevated myocardial stiffness in cardiac amyloidosis.

Authors:  Arvin Arani; Shivaram P Arunachalam; Ian C Y Chang; Francis Baffour; Phillip J Rossman; Kevin J Glaser; Joshua D Trzasko; Kiaran P McGee; Armando Manduca; Martha Grogan; Angela Dispenzieri; Richard L Ehman; Philip A Araoz
Journal:  J Magn Reson Imaging       Date:  2017-02-25       Impact factor: 4.813

3.  Causes of altered ventricular mechanics in hypertrophic cardiomyopathy: an in-silico study.

Authors:  Ekaterina Kovacheva; Tobias Gerach; Steffen Schuler; Marco Ochs; Olaf Dössel; Axel Loewe
Journal:  Biomed Eng Online       Date:  2021-07-22       Impact factor: 2.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.